Back to top

Lifeward: Buy Rating Reiterated as Partner-Led Growth Strategy Drives Momentum; 12-Month Price Target Maintained at $10

Lifeward, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula Ramakanth from H.C. Wainwright maintain...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lifeward Ltd. (LFWD)